Taraxasterol ameliorates bone loss of ovariectomized mice via suppressing the NLRP3 inflammasome and modulating the gut microbiota

Key Points

• Bone loss is reduced in ovariectomized mice treated with taraxasterol, indicating therapeutic potential for osteoporosis.
• Specifically, the treatment decreases activity of the nlrp3 inflammasome while positively affecting gut microbiota composition.
• Assessment using animal models shows significant modulation of inflammatory pathways linked to bone health.
• These findings highlight the need for further studies on taraxasterol's effects in human populations to validate its therapeutic implications.